Apparatus for delivery of pharmaceuticals to the cochlea
First Claim
Patent Images
1. An implantable tissue-stimulating device comprising:
- a resiliently flexible elongate member having a plurality of electrodes mounted thereon; and
a bio-active substance delivery means adapted to deliver at least one bio-active substance to the implantee following implantation of the device.
1 Assignment
0 Petitions
Accused Products
Abstract
An implantable tissue-stimulating device, such as a cochlear implant, having a resiliently flexible elongate member (11) having a plurality of electrodes (12) positioned thereon. The elongate member (11) provides a means of delivering at least one bio-active substance to the implantee following implantation of the elongate member (11). The delivery means can comprise a lumen 21 containing the bio-active substance in a liquid form. The bio-active substance can comprise a steroid or can perform a function of reducing the resting neuron potential of neurons within the cochlea.
-
Citations
42 Claims
-
1. An implantable tissue-stimulating device comprising:
-
a resiliently flexible elongate member having a plurality of electrodes mounted thereon; and
a bio-active substance delivery means adapted to deliver at least one bio-active substance to the implantee following implantation of the device. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)
-
-
36. An implantable tissue-stimulating device comprising:
a resiliently flexible elongate member having a plurality of electrodes mounted thereon, the elongate member surrounding a sealable reservoir for storing within the member at least one bio-active substance for delivery to an implantee following implantation of the device.
-
37. A cochlear implant electrode assembly comprising:
a resiliently flexible elongate member having a plurality of electrodes mounted thereon, the elongate member surrounding a sealable reservoir for storing within the member at least one bio-active substance for delivery to a cochlea of an implantee following implantation of the device. - View Dependent Claims (38, 39, 40, 41, 42)
Specification